SEC Form 4 · accession 0001225208-17-000412

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP & President, MedSurg

Period of report

Jan 1, 2017

Accepted (ET)

Jan 4, 2017 · 4:40 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000885725

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jan 1, 2017	M	17,510	$0.00	A	107,596	D
Common Stock^F2	Jan 1, 2017	F	5,964	$21.63	D	101,632	D
Common Stock^F3	holding	—	—		—	2,422	I	By 401(k)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Performance Share Units^F1,F4	—	Jan 1, 2017	M	17,510	D	Dec 31, 2016	Dec 31, 2016	Common Stock	17,510	0	D

F1On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2014 adjusted free cash flow measured against its 2014 financial plan over the one-year performance period ending December 31, 2014 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2016.
F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F4Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.